Clinical Trials Logo

Gastroscopy clinical trials

View clinical trials related to Gastroscopy.

Filter by:
  • Not yet recruiting  
  • Page 1

NCT ID: NCT06303037 Not yet recruiting - Sedation Clinical Trials

Effect of Esketamine on 95% Induction Dose of Remimazolam

EEIDR
Start date: April 2024
Phase: Phase 4
Study type: Interventional

As an invasive operation, gastroscopy will cause children's nervousness, anxiety and uncooperative behavior, and even lead to the risk of bleeding and perforation, which will also affect the accuracy of the examination results.The purpose of this study is to explore the influence of different doses of esketamine on the induced dose ED95 of remazolam during gastroscopic placement in children, and to provide theoretical basis for the combined use of remimazolam besylate and esketamine in gastroscopic anesthesia in children.

NCT ID: NCT05693298 Not yet recruiting - Gastroscopy Clinical Trials

High Flow Nasal Cannula in Patients Undergoing Gastroscopy

Start date: February 1, 2023
Phase: N/A
Study type: Interventional

During gastroscopy, the insertion of the fiberscope and gastric distension required to perform the examination may induce modifications to respiratory mechanics, respiratory effort and breathing pattern. High-flow nasal cannula (HFNC) therapy is a mixed air-oxygen supply system able to deliver heated humidified gas up to 60 L/min of flow rate, with an inspiratory oxygen fraction (FiO2) ranging from 21% to 100%. Increasing evidence supports the use of HFNC in several clinical conditions and settings. When compared to standard therapy (ST), HFNC results in enhanced gas exchange and improved comfort. No studies have yet assessed the benefits of HFNC versus ST during and after gastroscopy. We designed this unblinded randomized controlled trial to assess whether HFNC, compared to ST, improves oxygenation at the end of the procedure (primary endpoint). Additional endpoints were: 1) the lowest peripheral saturation of oxygen (SpO2) and the number of oxygen desaturations; 2) the changes of end-expiratory lung impedance and tidal impedance assessed by Electrical Impedance Tomography (EIT); 3) the effects on diaphragm function assessed by ultrasound (DUS).